US 9585878
Treatment of BDNF-related disorders using laquinimod
granted A61KA61K31/138A61K31/428
Quick answer
US patent 9585878 (Treatment of BDNF-related disorders using laquinimod) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/138, A61K31/428, A61K31/4704, A61K9/0053